Differentiating COVID-associated myocarditis from other Diseases: Difference between revisions
Jump to navigation
Jump to search
Line 10: | Line 10: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac [[biomarkers]], [[ventricular dysfunction]] such as including [[COVID-19-associated myocardial infarction| | COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac [[biomarkers]], [[ventricular dysfunction]] such as including [[COVID-19-associated myocardial infarction|acute coronary syndrome]], [[COVID-19-associated stress cardiomyopathy|stress-induced cardiomyopathy]] ([[takotsubo cardiomyopathy]]) and [[COVID-19-associated heart failure|heart failure]]. | ||
<small> | <small> | ||
{| | {| | ||
Line 41: | Line 41: | ||
*[[Pericardial effusion]] may be detectable | *[[Pericardial effusion]] may be detectable | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Non-specific:may show nonspecific ST-T abnormalities, [[sinus tachycardia]] and [[conduction abnormalities]] (such as bundle-branch blocks or atrioventricular conduction delays) | * Non-specific:may show nonspecific ST-T abnormalities, [[sinus tachycardia]] and [[conduction abnormalities]] (such as [[bundle branch block|bundle-branch blocks]] or [[atrioventricular block|atrioventricular conduction delays]]) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Non-specific: In [[fulminant myocarditis]], cardiac chamber sizes are usually normal with an increased septal thickness (secondary to acute myocardial edema), whereas in acute [[myocarditis]] marked left ventricular dilation and normal wall thickness might be seen. | *Non-specific: In [[fulminant myocarditis]], cardiac chamber sizes are usually normal with an increased septal thickness (secondary to acute myocardial edema), whereas in acute [[myocarditis]] marked left [[ventricular]] dilation and normal wall thickness might be seen. | ||
*[[Pericardial effusion]] may be be seen. | *[[Pericardial effusion]] may be be seen. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*CMR: T2-weighted edema imaging shows the presence of “acute myocardial | *CMR: T2-weighted [[edema]] imaging shows the presence of “acute [[myocardial]] [[inflammation]]”. "Late gadolinium enhancement (LGE) imaging” can demonstrate [[myocardial]] damage. | ||
| style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]] | | style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]] level | ||
|- | |- | ||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated myocardial infarction]] | |style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated myocardial infarction]] | ||
Line 59: | Line 59: | ||
*No specific X-ray findings | *No specific X-ray findings | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*ST elevation MI (STEMI) | *[[ST elevation MI]] ([[STEMI]]) | ||
*Non-ST elevation MI (NSTEMI) or Non Q wave | *[[Non-ST elevation MI]] ([[NSTEMI]]) or Non Q wave | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Localized wall motion abnormalities | *Localized wall motion abnormalities | ||
*Diffuse hypokinesia | *Diffuse hypokinesia | ||
*Left ventricular ejection fraction was lower than 50% in about 61% of the individuals. | *Left ventricular [[ejection fraction]] was lower than 50% in about 61% of the individuals. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
- | - | ||
Line 126: | Line 126: | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*[[Lobar | *[[Lobar Consolidation]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Prolonged PR interval | *Prolonged [[PR interval]] | ||
*Transient T wave inversions | *Transient [[T wave]] inversions | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*CT: [[Lobar | *CT: [[Lobar Consolidation]] | ||
| style="background: #F5F5F5; padding: 5px;" | Increased inflammatory markers, including [[ESR]], [[ | | style="background: #F5F5F5; padding: 5px;" | Increased [[inflammatory markers]], including [[ESR]], hs-[[CRP]] | ||
|- | |- | ||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated acute respiratory distress syndrome|COVID-19-associated acute respiratory distress syndrome | |style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated acute respiratory distress syndrome|COVID-19-associated acute respiratory distress syndrome]] | ||
]] | |||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" |- | ||
Line 147: | Line 146: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Signs of RV dysfunction/RV dilatation may be seen. | *Signs of [[Right ventricle|RV]] dysfunction/[[Right ventricle|RV]] dilatation may be seen. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*CT: Bilateral [[ground-glass opacities]] | *CT: Bilateral [[ground-glass opacities]] | ||
Line 160: | Line 159: | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*May show [[Fleischner sign]] (enlarged pulmonary artery), [[Hampton hump]], [[Westermark's sign]] | *May show [[Fleischner sign]] (enlarged [[pulmonary artery]]), [[Hampton hump]], [[Westermark's sign]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Non-specific:may show [[S1Q3T3]] pattern | * Non-specific:may show [[S1Q3T3]] pattern | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*May show signs of RV strain, | *May show signs of [[Right ventricle|RV]] strain, [[Right ventricle|RV]] dilatation, [[Right ventricle|RV]] dysfunction (if large PE) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*On CT angiography: Intra-luminal filling defect | *On CT angiography: Intra-luminal filling defect |
Revision as of 08:40, 24 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including Acute Coronary Syndrome, Stress-induced cardiomyopathy (Takotsubo cardiomyopathy) and Heart failure.
Differential Diagnosis
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including acute coronary syndrome, stress-induced cardiomyopathy (takotsubo cardiomyopathy) and heart failure.
Diseases | Symptoms | Physical Examination | Diagnostic tests | Other Findings | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dyspnea on Exertion | Chest Pain | Hemoptysis | Fever | Tachypnea | Tachycardia | Chest X-ray | ECG | Echocardiography | CT scan and CMR | ||
COVID-19-associated myocarditis | ✔ | ✔ | - | ✔ | ✔ | ✔ |
|
|
|
|
Increased cardiac troponin level |
COVID-19-associated myocardial infarction | ✔ | ✔ | - | ✔/- | ✔/- | ✔/- |
|
|
|
- |
Increased cardiac troponin levels |
COVID-19-associated stress cardiomyopathy | ✔ | ✔ | - | - | ✔ | ✔ |
|
|
|
|
Increased cardiac troponin and pro-BNP level, transient increase in catecholamine levels. |
COVID-19-associated heart failure | ✔ | - | ✔ | - | ✔ | ✔ |
|
|
|
|
Increased NT-proBNP and cardiac troponins levels |
COVID-19-associated pneumonia | ✔ | ✔ (Pleuritic) | ✔ | ✔ (Usually high) | ✔ | ✔ |
|
- | Increased inflammatory markers, including ESR, hs-CRP | ||
COVID-19-associated acute respiratory distress syndrome | ✔ | - | ✔ | ✔ | ✔ | ✔ |
|
- |
|
- | |
COVID-19-associated pulmonary embolism | ✔ (Usually sudden-onset) | ✔ (Pleauritic) | ✔ (If massive PE) | ✔ (Low-grade) | ✔ | ✔ |
|
|
|
|